Addressing the challenge of opioid tolerance and overdose, Cleveland Clinic research finds new treatment option may improve opioid therapy.
Stem cells show potential as disease-modifying and restorative therapy in a range of nervous system disorders, but they’re far from ready for prime time. An expert outlines the reasons why and the road ahead.
Studies at Cleveland Clinic have demonstrated the effectiveness of mesenchymal stem cell (MSC) transplantation in reducing hyperalgesia caused by nerve injury. Jianguo Cheng, MD, PhD, talks about findings from animal studies.
Discoveries uncover underlying mechanisms of fibrosis, opening the door to exciting new therapies for fibrotic disorders.